NVAX
Price:
$7.34
Market Cap:
$1.21B
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The c...[Read more]
Industry
Biotechnology
IPO Date
1995-12-05
Stock Exchange
NASDAQ
Ticker
NVAX
According to Novavax, Inc.’s latest financial reports and current stock price. The company's current ROE is 89.73%. This represents a change of -11.40% compared to the average of 101.27% of the last 4 quarters.
The mean historical ROE of Novavax, Inc. over the last ten years is 570.30%. The current 89.73% ROE has changed -84.27% with respect to the historical average. Over the past ten years (40 quarters), NVAX's ROE was at its highest in in the December 2016 quarter at 1.03%. The ROE was at its lowest in in the March 2025 quarter at -685.65%.
Average
570.30%
Median
89.90%
Minimum
-344.65%
Maximum
5.05%
Discovering the peaks and valleys of Novavax, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 5.05%
Minimum Annual Increase = -9514.06%
Minimum Annual ROE = -344.65%
| Year | ROE | Change |
|---|---|---|
| 2025 | -344.65% | -1246.71% |
| 2024 | 30.06% | -60.47% |
| 2023 | 76.03% | -26.73% |
| 2022 | 103.76% | -79.07% |
| 2021 | 495.84% | -843.55% |
| 2020 | -66.69% | -195.35% |
| 2019 | 69.94% | -36.42% |
| 2018 | 110.01% | -39.10% |
| 2017 | 180.64% | -96.42% |
| 2016 | 5.05% | -9514.06% |
The current ROE of Novavax, Inc. (NVAX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-79.52%
5-year avg
72.21%
10-year avg
570.30%
Novavax, Inc.’s ROE is less than CureVac N.V. (23.04%), greater than Zenas BioPharma, Inc. (-167.71%), greater than Terns Pharmaceuticals, Inc. (-20.02%), greater than Upstream Bio, Inc. (-43.82%), greater than Wave Life Sciences Ltd. (-56.41%), greater than Trevi Therapeutics, Inc. (-24.53%), greater than Intellia Therapeutics, Inc. (-57.27%), greater than Precigen, Inc. (-1768.51%), greater than Nektar Therapeutics (-87.00%), greater than ORIC Pharmaceuticals, Inc. (-35.33%),
| Company | ROE | Market cap |
|---|---|---|
| 23.04% | $1.05B | |
| -167.71% | $1.96B | |
| -20.02% | $4.77B | |
| -43.82% | $348.83M | |
| -56.41% | $1.12B | |
| -24.53% | $2.57B | |
| -57.27% | $1.21B | |
| -1768.51% | $1.94B | |
| -87.00% | $1.38B | |
| -35.33% | $1.17B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novavax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novavax, Inc.'s ROE?
How is the ROE calculated for Novavax, Inc. (NVAX)?
What is the highest ROE for Novavax, Inc. (NVAX)?
What is the 3-year average ROE for Novavax, Inc. (NVAX)?
What is the 5-year average ROE for Novavax, Inc. (NVAX)?
How does the current ROE for Novavax, Inc. (NVAX) compare to its historical average?